Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of ezetimibe 10 mg added daily to ongoing treatment with atorvastatin
10 mg daily versus ezetimibe placebo added daily to ongoing treatment with atorvastatin 10 mg
daily in reducing the concentration of LDL-cholesterol (LDL-C) at endpoint after 6 weeks of
treatment.